Tennis champ McEnroe teams up with GSK for public-education initiative
PHILADELPHIA Three-time Wimbledon and four-time U.S. Open Champion John McEnroe has teamed with GlaxoSmithKline to create a public-education initiative entitled the “50 Over 50 Prostate Health Challenge.”
“I just celebrated my 50th birthday, and while I’m still as active as ever, I know there are certain health issues I need to stay on top of, including my prostate health,” McEnroe said. “Now I’m asking other men to take the ’50 Over 50 Prostate Health Challenge.’ It’s all about talking to your doctor and getting serious about your prostate health.”
As a part of the campaign, an interactive web site, www.50over50challenge.com, has been created where men can start the “Prostate Health Challenge.” The challenge is to take three steps to get serious about prostate health: a brief online prostate health assessment; seeing a doctor for a prostate-health exam; and knowing your PSA (Prostate-specific antigen) level.
PSA level, ascertained through a blood test, is a protein marker that can rise when a prostate condition is present.
McEnroe will also be featured in public education video messages that will appear throughout the year on network television, Internet sites and at 50over50challenge.com. The first video vignette will air April 4 in between the first and second games of the men’s college basketball semi-final on CBS. There will also be national print messages in March and April running in such publications as USA Today, Sports Illustrated, Time and Newsweek.
“Prostate health can be awkward to talk about, so we’ve created a series of hopefully memorable, vignettes to help get men talking,” McEnroe said. “I am hoping my involvement will be motivational and encourage men to take the Challenge and take control of their prostate health.”
CV Therapeutics’ board of directors rejects Astellas’ tender offer
PALO ALTO, Calif. The board of directors of CV Therapeutics announced Friday it has rejected Astellas’ tender offer of $16 per share.
CV Therapeutics’ determined that the offer “undervalues the company and is not in the best interests of its stockholders”, according to a release.
The announcement comes once day after Gilead Sciences announced it would acquire CV Therapeutics, making it a wholly owned subsidiary of Gilead. The transaction is valued at approximately $1.4 billion, with a tender offer of $20 per share.
Take Care Health Systems opens new clinic in Phoenix
CONSHOHOCKEN, Pa. Take Care Health Systems, which is owned by Walgreens, has opened a new clinic in the Phoenix market, the clinic operator announced on Friday.
With the new opening, the company now has 18 clinics in that market.
Take Care Health Systems operates a total of 339 clinics in 35 markets throughout 19 states.